Although genetic testing is not required to make the diagnosis of HHT, the second International Guideline suggests genetic testing for all individuals with HHT, as it may facilitate family testing and additional evaluations (e.g., screening colonoscopies for individuals with pathogenic variants in the SMAD4 gene). Here, SMAD4 is linked to hereditary hemorrhagic telangiectasia.